GR1002177B - Method of preparation of injectable clarithromycin - Google Patents

Method of preparation of injectable clarithromycin

Info

Publication number
GR1002177B
GR1002177B GR900100402A GR900100402A GR1002177B GR 1002177 B GR1002177 B GR 1002177B GR 900100402 A GR900100402 A GR 900100402A GR 900100402 A GR900100402 A GR 900100402A GR 1002177 B GR1002177 B GR 1002177B
Authority
GR
Greece
Prior art keywords
preparation
clarithromycin
injectable
injectable clarithromycin
Prior art date
Application number
GR900100402A
Other languages
Greek (el)
Other versions
GR900100402A (en
Inventor
Chiang-Chung Hsu
B John Cannon
Michael W Lovell
Wah-Ho Hui
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of GR900100402A publication Critical patent/GR900100402A/en
Publication of GR1002177B publication Critical patent/GR1002177B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10C—WORKING-UP PITCH, ASPHALT, BITUMEN, TAR; PYROLIGNEOUS ACID
    • C10C3/00—Working-up pitch, asphalt, bitumen
    • C10C3/002—Working-up pitch, asphalt, bitumen by thermal means
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10C—WORKING-UP PITCH, ASPHALT, BITUMEN, TAR; PYROLIGNEOUS ACID
    • C10C3/00—Working-up pitch, asphalt, bitumen
    • C10C3/06—Working-up pitch, asphalt, bitumen by distillation
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F9/00—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments
    • D01F9/08—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments of inorganic material
    • D01F9/12—Carbon filaments; Apparatus specially adapted for the manufacture thereof
    • D01F9/14—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments
    • D01F9/145—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments from pitch or distillation residues
    • D01F9/155—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments from pitch or distillation residues from petroleum pitch
GR900100402A 1989-05-26 1990-05-28 Method of preparation of injectable clarithromycin GR1002177B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35828389A 1989-05-26 1989-05-26

Publications (2)

Publication Number Publication Date
GR900100402A GR900100402A (en) 1991-10-10
GR1002177B true GR1002177B (en) 1996-03-07

Family

ID=23409043

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100402A GR1002177B (en) 1989-05-26 1990-05-28 Method of preparation of injectable clarithromycin

Country Status (9)

Country Link
EP (1) EP0473707A4 (en)
JP (1) JP2963537B2 (en)
KR (1) KR920700655A (en)
AU (1) AU630469B2 (en)
CA (1) CA2056445A1 (en)
GR (1) GR1002177B (en)
IL (1) IL94516A (en)
NZ (1) NZ233827A (en)
WO (1) WO1990014094A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
DE4447972B4 (en) * 1993-05-27 2007-12-27 Novartis Ag Pharmaceutical preparations contg macrolide antibiotics - contain, as the carrier, a mixt of a hydrophilic phase, a lipophilic phase and a surfactant
CH686761A5 (en) 1993-05-27 1996-06-28 Sandoz Ag Pharmaceutical formulations.
DE4410637C1 (en) * 1994-03-26 1995-09-21 Boehringer Ingelheim Vetmed Injectable solutions of dirithromycin
US5795871A (en) * 1994-04-26 1998-08-18 Nobuhiro Narita Pharmaceutical composition for treatment of non-small cell lung cancer
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
US6017948A (en) * 1998-10-30 2000-01-25 Supergen, Inc. Water-miscible pharmaceutical compositions
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
WO2003049716A1 (en) * 2001-12-13 2003-06-19 Ranbaxy Laboratories Limited Stable topical formulation of clarithromycin
US20050049209A1 (en) * 2003-08-06 2005-03-03 Chen Andrew Xian Pharmaceutical compositions for delivering macrolides
US7871632B2 (en) 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
WO2007102241A1 (en) 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. External pharmaceutical composition
CA2645070C (en) * 2006-03-08 2014-02-04 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
ES2591030T3 (en) 2007-09-05 2016-11-24 Pola Pharma Inc. Antifungal Pharmaceutical Composition
JP5345937B2 (en) 2007-09-05 2013-11-20 株式会社ポーラファルマ Antifungal composition
WO2009031642A1 (en) 2007-09-05 2009-03-12 Pola Pharma Inc. Pharmaceutical composition
EP2416757A2 (en) 2009-04-09 2012-02-15 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5688406B2 (en) 2009-04-09 2015-03-25 株式会社ポーラファルマ Antifungal pharmaceutical composition
KR101754697B1 (en) 2009-08-25 2017-07-06 가부시키가이샤 폴라 파마 Antimycotic pharmaceutical composition
CN105658203B (en) 2013-11-08 2021-03-16 株式会社活效制药 Aqueous suspension of nanoparticles containing macrolide antibacterial agents
CN110234322A (en) * 2017-04-03 2019-09-13 消化***疾病中心 The application of psoriasic antibiotic compound is treated for treating streptococcal infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61291520A (en) * 1985-06-19 1986-12-22 Daigo Eiyou Kagaku Kk Fat emulsion of erythromycin
IL87219A0 (en) * 1987-08-07 1988-12-30 Abbott Lab Erythromycin formulations for oral administration
US5338761A (en) * 1988-09-29 1994-08-16 Shiseido Company Ltd. Emulsified composition

Also Published As

Publication number Publication date
WO1990014094A1 (en) 1990-11-29
JPH04505762A (en) 1992-10-08
IL94516A (en) 1994-12-29
EP0473707A4 (en) 1992-12-09
AU5811090A (en) 1990-12-18
CA2056445A1 (en) 1990-11-27
AU630469B2 (en) 1992-10-29
IL94516A0 (en) 1991-03-10
NZ233827A (en) 1991-06-25
JP2963537B2 (en) 1999-10-18
EP0473707A1 (en) 1992-03-11
GR900100402A (en) 1991-10-10
KR920700655A (en) 1992-08-10

Similar Documents

Publication Publication Date Title
GR1002177B (en) Method of preparation of injectable clarithromycin
PL286019A1 (en) Method of obtaining heteroazepines
PL286707A1 (en) Method of obteining tetraniture
EP0421644A3 (en) Method for preparation of organoalkoxysilanes
GR900100319A (en) Novel thieno-triazolo-diazepino-derivatives preparation method
GR900100795A (en) Injectable solution and preparation process therefor
EP0435149A3 (en) Method of producing 3-dibutyl-amino-6-methyl-7-anilinofluoran
ZA904311B (en) Method of preparing n-oxo-tetrahydro-beta-carbolines
EP0416577A3 (en) Method of preparing levoglucosenone
GB2236204B (en) Method of extending buffer
CS51189A2 (en) Method of 1-methoxy-2-propanone preparation
CS279089A1 (en) Method of 1-amino-7-naphthol preparation
CS214389A1 (en) Method of lysinesalicylate preparation
CS23489A1 (en) Method of z-alkenes preparation
CS35489A1 (en) Method of normethanephrine preparation
CS841188A1 (en) Method of trisdiethylaminosiliciumchloride preparation
CS599789A1 (en) Method of cobalt-zinc double cyclo-tetraphosphates preparation
CS289889A1 (en) Method of double manganese-cobalt cyclo-tetraphosphates preparation
CS118689A1 (en) Method of technical 2-isopropylamino-4-ethylamino-6-chloro-s-triazine
BG47579A1 (en) Method for preparation of photoluminophors
PL281664A1 (en) Method of obtaining chloromethylepoxybutanes
PL282259A1 (en) Method of obtaining l-pyroglutamylo-l-histidyl-l-tryptophyl-l-seril-l-thyrosilgliosyl-l-leukocyl-l-arginyl-l-polyglycinamide
PL282583A1 (en) Method of obtaining 1-methylethylbenzene
PL280933A1 (en) Method of obtaining 2-chloroethyl-3-chloropropylsulfide
CS8902792A1 (en) 2-acetamido-2-deoxy-beta-d-glucopyranozylmethylamine and method of its preparation

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees